Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126548) titled 'Platelet function and genetic testing for predicting and guiding individualized antiplatelet therapy' on June 11.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Drum Tower Hospital
Condition:
Ischemic Stroke
Intervention:
Individualized adjustment group:Cilostazol 100mg bid
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2021-12-18
Target Sample Size: Individualized adjustment group:400;No adjustment Group:400;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=312454
Disclaimer: Curated...